CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,389 enrolled
Drug / intervention
Advanced AMS program +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04848883
NCT04848883N/ACompleted

Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care: a Cluster-randomised Blinded Study (IDASP)

Institut d'Investigació Biomèdica de Bellvitge·interventional·Posted Apr 19, 2021·Updated Mar 23, 2026

In Brief

A clinical study evaluating Advanced AMS program and Standard AMS program for Infectious Disease. Completed, enrolled 1,389 participants across 1 site.

Detailed Summary

A cluster-randomised multicentre blinded clinical trial will be performed in six primary care centres located in the southern metropolitan area of Barcelona (Spain). The objective is to assess whether including experts on infectious diseases (ID) within the antimicrobial stewardship (AMS) team of primary care achieves higher reductions on overall antibiotic consumption and increases the quality of prescription in diagnosed upper respiratory and urinary tract infections. Centres will be randomly assigned to receive a standard-AMS or an advanced-AMS (intervention). Advanced-AMS includes all standard-AMS strategies plus general practitioner chance to discuss clinical cases by telephone to ID expert on working days (8:00 am to 8:00 pm), and by biweekly meetings.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 19, 2021
Enrollment StartJun 1, 2021
Primary CompletionApr 21, 2023
Study CompletionJun 30, 2024
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.2 years ago

Interventions

Advanced AMS programbehavioral

1. \- Telephone acces to infectious disease experts to discuss patients' therpies during working days. 2. \- Biweeckly meetings with infectious diseases experts and antimicrobial stewardship group.

Standard AMS programbehavioral

1. \- Educational materials. 2. \- Updated local antibiotic guidelines. 3. \- Promotion of delayed antibiotic prescription. 4. \- Promotion of Streptococcus pyogenes antigen test (Streptotest) if bacterial tonsillitis is suspected. 5. \- Daily report to GP of multiresistant bacteria isolates in urinary samples. 6. \- Quarterly reports to prescribers of AMS outcomes at the centre-level.